5AM Opportunities II (GP), LLC — SEC Form 4 filings
SEC reporting owner CIK 1873515. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-07-24 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 4,683,599 shares, $24,499,985 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 833,333 shares @ $12.00 ($9,999,996) in Artiva Biotherapeutics, Inc., filed 2024-07-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Camp4 Therapeutics Corp (CAMP) | 10% owner | 3 | 2 legs · 3,850,266 sh · $14,499,989 | — | 6 |
| Artiva Biotherapeutics, Inc. (ARTV) | 10% owner | 1 | 1 leg · 833,333 sh · $9,999,996 | — | 5 |
| Latigo Biotherapeutics, Inc. (LTGO) | 10% owner | 1 | — | — | 6 |
Form 4 filings — 5AM Opportunities II (GP), LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Latigo Biotherapeutics, Inc. (LTGO) jointly with 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., PARMAR KUSH, Schwab Andrew J. | Conversion (C): 4,975,543 · Conversion (C): 2,350,419 · Conversion (C): 3,152,305 (derivative) @ $0 · Conversion (C): 1,823,238 (derivative) @ $0 · Conversion (C): 866,018 (derivative) @ $0 · Conversion (C): 1,484,401 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Camp4 Therapeutics Corp (CAMP) jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II, L.P., 5AM Partners VII, LLC, 5AM Ventures VII, L.P., PARMAR KUSH | Purchase (P): 3,179,558 (derivative) @ $1.53 | EDGAR |
| 2025-09-15 | 4 | Camp4 Therapeutics Corp (CAMP) jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II, L.P., 5AM Partners VII, LLC, 5AM Ventures VII, L.P., PARMAR KUSH | Purchase (P): 2,941,176 @ $1.53 | EDGAR |
| 2024-10-15 | 4 | Camp4 Therapeutics Corp (CAMP) jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II, L.P., PARMAR KUSH | Conversion (C): 1,716,055 · Conversion (C): 302,770 · Purchase (P): 909,090 @ $11 · Conversion (C): 15,002,166 (derivative) · Conversion (C): 4,244,770 (derivative) · Conversion (C): 3,395,816 (derivative) | EDGAR |
| 2024-07-24 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II, L.P., PARMAR KUSH, Schwab Andrew J. | Conversion (C): 1,058,284 · Other (J): 112,966 @ $10.20 · Other (J): 348,721 @ $10.20 · Purchase (P): 833,333 @ $12 · Conversion (C): 843,592 (derivative) · Conversion (C): 214,692 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1873515 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →